CLINICAL_TRIALS
trial_result
· 2018-11-26
Clinical Trial Update: Evaluation of Molecular Markers in Adrenal Tumors
Summary
Clinical trial evaluating molecular markers in adrenal tumors was terminated; results posted in 2018.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: National Cancer Institute (NCI) | Conditions: Adrenal Gland Neoplasms | Status: TERMINATED | Results posted: 2018-11-26